148 related articles for article (PubMed ID: 10822467)
1. Therapy of chronic myelogenous leukemia.
Talpaz M; Kantarjian H; McCredie K; Trujillo J; Keating M; Gutterman JU
Cancer; 1987 Feb; 59(3 Suppl):664-7. PubMed ID: 10822467
[TBL] [Abstract][Full Text] [Related]
2. A phase II study alternating alpha-2a-interferon and gamma-interferon therapy in patients with chronic myelogenous leukemia.
Talpaz M; Kurzrock R; Kantarjian H; Rothberg J; Saks S; Evans L; Gutterman JU
Cancer; 1991 Nov; 68(10):2125-30. PubMed ID: 1913450
[TBL] [Abstract][Full Text] [Related]
3. Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patients.
Talpaz M; Kantarjian H; Kurzrock R; Trujillo JM; Gutterman JU
Ann Intern Med; 1991 Apr; 114(7):532-8. PubMed ID: 2001086
[TBL] [Abstract][Full Text] [Related]
4. Interferon alfa as primary treatment of chronic myeloid leukemia: long-term follow-up of 71 patients observed in a single center.
Kloke O; Opalka B; Niederle N
Leukemia; 2000 Mar; 14(3):389-92. PubMed ID: 10720131
[TBL] [Abstract][Full Text] [Related]
5. Southern technique and cytogenetics are complementary and must be used together in the evaluation of Ph1, M-BCR positive chronic myeloid leukemia (CML) patients treated with alpha interferon (IFN-alpha).
Steegmann JL; Requena MJ; Casado LF; Pico M; Peñarrubia MJ; Ferro MT; Resino M; Fernandez-Rañada JM
Am J Hematol; 1996 Nov; 53(3):169-74. PubMed ID: 8895687
[TBL] [Abstract][Full Text] [Related]
6. Interferon alfa-2a (Roferon-A) monotherapy in chronic myelogenous leukemia: a pilot study in Nigerian patients in early chronic phase.
Okanny CC; Durosimi MA; Chukwuani CM; Njoku OS; Akinola NO; Herrada SC; Ogbe OP; Onwukeme KE; Faluyi JO; Akanmu AS; Akinsete I
West Afr J Med; 2000; 19(4):286-92. PubMed ID: 11391843
[TBL] [Abstract][Full Text] [Related]
7. [Monitoring of the therapeutic response of interferon to chronic myeloid leukemia by duel-color fluorescence in situ hybridization].
Song YQ; Li W; Kong LH; Wang GJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb; 11(1):38-40. PubMed ID: 12667287
[TBL] [Abstract][Full Text] [Related]
8. Interferon alfa-2b in acute- and chronic-phase chronic myelogenous leukaemia: initial response and long-term results in 54 patients.
Niederle N; Moritz T; Kloke O; Wandl U; May D; Becher R; Franz T; Opalka B; Schmidt CG
Eur J Cancer; 1991; 27 Suppl 4():S7-14. PubMed ID: 1799485
[TBL] [Abstract][Full Text] [Related]
9. Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-alpha-based therapy.
Martinelli G; Testoni N; Amabile M; Bonifazi F; De Vivo A; Farabegoli P; Terragna C; Montefusco V; Ottaviani E; Saglio G; Russo D; Baccarani M; Rosti G; Tura S
Bone Marrow Transplant; 2000 Apr; 25(7):729-36. PubMed ID: 10745258
[TBL] [Abstract][Full Text] [Related]
10. Interferon alfa-2c in chronic myelogenous leukemia (CML): hematologic, cytogenetic and molecular-genetic response of patients with chronic phase CML previously resistant to therapy with interferon gamma.
Herrmann F; Jonas D; Helfrich SG; Lindemann A; Schleiermacher E; Mertelsmann R
Blut; 1990 Oct; 61(4):226-31. PubMed ID: 2121299
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic myeloid leukemia with interferon alpha (Roferon): results of the Israeli Study Group on CML.
Shtalrid M; Lugassy G; Rosensaft J; Berrebi A
Leuk Lymphoma; 1993; 11 Suppl 1():193-7. PubMed ID: 8251895
[TBL] [Abstract][Full Text] [Related]
12. [Disappearance of Philadelphia chromosomes after remission induction in lymphoid crisis of chronic myelogenous leukemia].
Nagafuji K; Iwakiri R; Miyamoto T; Okamura H; Yokota E; Matsumoto I
Rinsho Ketsueki; 1992 Sep; 33(9):1226-30. PubMed ID: 1433945
[TBL] [Abstract][Full Text] [Related]
13. Trisomy X in Philadelphia chromosome-negative cells during the course of Philadelphia chromosome-positive chronic myelocytic leukemia.
Hishida A; Yamamoto K; Matsushita T; Tanimoto M; Saito H; Emi N
Cancer Genet Cytogenet; 2003 Apr; 142(1):83-5. PubMed ID: 12660041
[TBL] [Abstract][Full Text] [Related]
14. Interferon alpha in the treatment of chronic myelogenous leukemia.
Robak T
Arch Immunol Ther Exp (Warsz); 1998; 46(6):347-53. PubMed ID: 9883313
[TBL] [Abstract][Full Text] [Related]
15. Response to alpha-interferon in children with Philadelphia chromosome-positive chronic myelocytic leukemia.
Dow LW; Raimondi SC; Culbert SJ; Ochs J; Kennedy W; Pinkel DP
Cancer; 1991 Oct; 68(8):1678-84. PubMed ID: 1833044
[TBL] [Abstract][Full Text] [Related]
16. Frequency of molecular elimination of Ph1 clone in chronic myelogenous leukemia (CML) with interferon alpha.
Henic N; Preudhomme C; Noel M; Lai J; Wetterwald M; Simon M; Fenaux P
Leukemia; 1996 Jan; 10(1):185-6. PubMed ID: 8558928
[No Abstract] [Full Text] [Related]
17. [Clonal evolution of abnormal Philadelphia chromosome-negative cells after imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia].
Jiang Q; Chen SS; Jiang B; Jiang H; Lu Y; Qiu JY; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):23-6. PubMed ID: 15946504
[TBL] [Abstract][Full Text] [Related]
18. Phase II, randomized, multicenter, comparative study of peginterferon-alpha-2a (40 kD) (Pegasys) versus interferon alpha-2a (Roferon-A) in patients with treatment-naïve, chronic-phase chronic myelogenous leukemia.
Lipton JH; Khoroshko N; Golenkov A; Abdulkadyrov K; Nair K; Raghunadharao D; Brummendorf T; Yoo K; Bergstrom B;
Leuk Lymphoma; 2007 Mar; 48(3):497-505. PubMed ID: 17454589
[TBL] [Abstract][Full Text] [Related]
19. Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies.
Talpaz M; Estrov Z; Kantarjian H; Ku S; Foteh A; Kurzrock R
J Clin Invest; 1994 Oct; 94(4):1383-9. PubMed ID: 7929813
[TBL] [Abstract][Full Text] [Related]
20. BCR rearrangement-negative chronic myelogenous leukemia revisited.
Kurzrock R; Bueso-Ramos CE; Kantarjian H; Freireich E; Tucker SL; Siciliano M; Pilat S; Talpaz M
J Clin Oncol; 2001 Jun; 19(11):2915-26. PubMed ID: 11387365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
